1-12 of 12
Miguel A. Villalona-Calero
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer

Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona-Calero, Daniel Dix, Justin I. Odegaard, Richard B. Lanman, Vassiliki A. Papadimitrakopoulou
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (15): 4691–4700.
https://doi.org/10.1158/1078-0432.CCR-19-0624
Published: 01 August 2019
View articletitled, Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer
Open the PDF for Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Shivaani Kummar, Amit M. Oza, Gini F. Fleming, Daniel M. Sullivan, David R. Gandara, Michael J. Naughton, Miguel A. Villalona-Calero, Robert J. Morgan, Jr, Peter M. Szabo, Ahrim Youn, Alice P. Chen, Jiuping Ji, Deborah E. Allen, Chih-Jian Lih, Michele G. Mehaffey, William D. Walsh, Paul M. McGregor, III, Seth M. Steinberg, P. Mickey Williams, Robert J. Kinders, Barbara A. Conley, Richard M. Simon, James H. Doroshow
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (7): 1574–1582.
https://doi.org/10.1158/1078-0432.CCR-14-2565
Published: 31 March 2015
View articletitled, Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer
Open the PDF for Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Mutant type specific lung cancer models for individualized treatment

Wenrui Duan, Li Gao, Xin Wu, Gregory A. Otterson, Miguel A. Villalona-Calero
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): B3.
Published: 15 August 2014
View articletitled, Mutant type specific lung cancer models for individualized treatment
Journal Articles

Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer

Gregory A. Otterson, Miguel A. Villalona-Calero, William Hicks, Xueliang Pan, John A. Ellerton, Scott N. Gettinger, John R. Murren
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (8): 2466–2473.
https://doi.org/10.1158/1078-0432.CCR-09-3015
Published: 14 April 2010
View articletitled, Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer
Open the PDF for Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer in another window
Journal Articles

Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs

Gregory A. Otterson, Miguel A. Villalona-Calero, Sunil Sharma, Mark G. Kris, Anthony Imondi, Mirjam Gerber, Dorothy A. White, Mark J. Ratain, Joan H. Schiller, Alan Sandler, Michael Kraut, Sridhar Mani, John R. Murren
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (4): 1246–1252.
https://doi.org/10.1158/1078-0432.CCR-06-1096
Published: 22 February 2007
View articletitled, Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs
Open the PDF for Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs in another window
Journal Articles

HDAC Inhibitors and Cardiac Safety

Manisha H. Shah, Miguel A. Villalona-Calero, Guido Marcucci, John C. Byrd, Michael R. Grever
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (3): 1068.
https://doi.org/10.1158/1078-0432.CCR-06-2380
Published: 08 February 2007
View articletitled, HDAC Inhibitors and Cardiac Safety
Open the PDF for HDAC Inhibitors and Cardiac Safety in another window
Journal Articles

Phase II Evaluation of Docetaxel-Modulated Capecitabine in Previously Treated Patients with Non–Small Cell Lung Cancer

Tamila Kindwall-Keller, Gregory A. Otterson, Donn Young, Anterpreet Neki, Tamara Criswell, Gerard Nuovo, Richie Soong, Robert Diasio, Miguel A. Villalona-Calero
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (5): 1870–1876.
https://doi.org/10.1158/1078-0432.CCR-04-1727
Published: 08 March 2005
View articletitled, Phase II Evaluation of Docetaxel-Modulated Capecitabine in Previously Treated Patients with Non–Small Cell Lung Cancer
Open the PDF for Phase II Evaluation of Docetaxel-Modulated Capecitabine in Previously Treated Patients with Non–Small Cell Lung Cancer in another window
Journal Articles

A Phase I/II Study of LY900003, an Antisense Inhibitor of Protein Kinase C-α, in Combination with Cisplatin and Gemcitabine in Patients with Advanced Non–Small Cell Lung Cancer

Miguel A. Villalona-Calero, Paul Ritch, Jose A. Figueroa, Gregory A. Otterson, Robert Belt, Edward Dow, Sebastian George, James Leonardo, Spence McCachren, G. Lance Miller, Manuel Modiano, Manuel Valdivieso, Richard Geary, Jennifer W. Oliver, Jon Holmlund
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (18): 6086–6093.
https://doi.org/10.1158/1078-0432.CCR-04-0779
Published: 24 September 2004
View articletitled, A Phase I/II Study of LY900003, an Antisense Inhibitor of Protein Kinase C-α, in Combination with Cisplatin and Gemcitabine in Patients with Advanced Non–Small Cell Lung Cancer
Open the PDF for A Phase I/II Study of LY900003, an Antisense Inhibitor of Protein Kinase C-α, in Combination with Cisplatin and Gemcitabine in Patients with Advanced Non–Small Cell Lung Cancer in another window
Journal Articles

Phase I Study of Low-Dose Suramin as a Chemosensitizer in Patients with Advanced Non-Small Cell Lung Cancer

Miguel A. Villalona-Calero, M. Guillaume Wientjes, Gregory A. Otterson, Steven Kanter, Donn Young, Anthony J. Murgo, Beth Fischer, Carrie DeHoff, Danny Chen, Teng-Kuang Yeh, SaeHeum Song, Michael Grever, Jessie L-S. Au
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3303–3311.
Published: 05 September 2003
View articletitled, Phase I Study of Low-Dose Suramin as a Chemosensitizer in Patients with Advanced Non-Small Cell Lung Cancer
Open the PDF for Phase I Study of Low-Dose Suramin as a Chemosensitizer in Patients with Advanced Non-Small Cell Lung Cancer in another window
Journal Articles

A Phase I and Pharmacokinetic Study of Ecteinascidin-743 on a Daily × 5 Schedule in Patients with Solid Malignancies

Miguel A. Villalona-Calero, S. Gail Eckhardt, Geoffrey Weiss, Manuel Hidalgo, Jos H. Beijnen, Charlotte van Kesteren, Hilde Rosing, Elizabeth Campbell, Maura Kraynak, Luis Lopez-Lazaro, Cecilia Guzman, Daniel D. Von Hoff, Jose Jimeno, Eric K. Rowinsky
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (1): 75–85.
Published: 01 January 2002
View articletitled, A Phase I and Pharmacokinetic Study of Ecteinascidin-743 on a Daily × 5 Schedule in Patients with Solid Malignancies
Open the PDF for A Phase I and Pharmacokinetic Study of Ecteinascidin-743 on a Daily × 5 Schedule in Patients with Solid Malignancies in another window
Journal Articles

A Phase I and Pharmacological Study of Protracted Infusions of Crisnatol Mesylate in Patients with Solid Malignancies

Miguel A. Villalona-Calero, Thierry Petit, John Kuhn, Patrick Cobb, Maura Kraynak, S. Gail Eckhardt, Ronald Drengler, Cecelia Simmons, Pedro Santabarbara, Daniel D. Von Hoff, Eric K. Rowinsky
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (11): 3369–3378.
Published: 01 November 1999
View articletitled, A Phase I and Pharmacological Study of Protracted Infusions of Crisnatol Mesylate in Patients with Solid Malignancies
Open the PDF for A Phase I and Pharmacological Study of Protracted Infusions of Crisnatol Mesylate in Patients with Solid Malignancies in another window
Journal Articles

A Phase I and Pharmacokinetic Study of Losoxantrone and Paclitaxel in Patients with Advanced Solid Tumors

Sami G. Diab, Sharyn D. Baker, Amita Joshi, Howard A. Burris, Patrick W. Cobb, Miguel A. Villalona-Calero, S. Gail Eckhardt, Geoffrey R. Weiss, Gladys I. Rodriguez, Ronald Drengler, Maura Kraynak, Lisa Hammond, Michael Finizio, Daniel D. Von Hoff, Eric K. Rowinsky
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (2): 299–308.
Published: 01 February 1999
View articletitled, A Phase I and Pharmacokinetic Study of Losoxantrone and Paclitaxel in Patients with Advanced Solid Tumors
Open the PDF for A Phase I and Pharmacokinetic Study of Losoxantrone and Paclitaxel in Patients with Advanced Solid Tumors in another window